The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clemens von Birgelen

Showing 1-20 of 38 articles
Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry
Mohamed M, Polad J, Hildick-Smith D, Bizeau O, Baisebenov R, Roffi M, Íñiguez-Romo A, Chevalier B, von Birgelen C, Roguin A, Aminian A, Angioi M, Mamas M
September 18, 2020 | 10.4244/EIJ-D-20-00361
Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry
Mohamed M, Polad J, Hildick-Smith D, Bizeau O, Baisebenov R, Roffi M, Íñiguez-Romo A, Chevalier B, von Birgelen C, Roguin A, Aminian A, Angioi M, Mamas M
June 25, 2020 | 10.4244/EIJ-D-20-00361
Involving the patient’s perspective and preferences concerning coronary angiography and percutaneous coronary intervention
Kok M, von Birgelen C
February 20, 2020 | 10.4244/EIJV15I14A221
Coronary interventions
Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial
Haude M, Ince H, Toelg R, Lemos P, von Birgelen C, Christiansen E, Wijns W, Neumann F, Eeckhout E, Garcia-Garcia H, Waksman R
February 7, 2020 | 10.4244/EIJ-D-18-01000
Coronary interventions
The obesity paradox revisited: body mass index and ­long-term outcomes after PCI from a large pooled patient-level database
Wolny R, Maehara A, Liu Y, Zhang Z, Mintz G, Redfors B, Madhavan M, Smits P, von Birgelen C, Serruys P, Mehran R, Leon M, Stone G
January 17, 2020 | 10.4244/EIJ-D-19-00467
Derivation and external validation of a novel risk score for prediction of 30-day mortality after percutaneous coronary intervention
Brener S, Leon M, Serruys P, Smits P, von Birgelen C, Mehran R, Kirtane A, Witzenbichler B, Rinaldi M, Metzger C, Mazzaferri E, Zhang Z, Stone G
August 9, 2019 | 10.4244/EIJ-D-19-00262
Coronary interventions
BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: three-year clinical outcomes of the PIONEER trial
Chang C, Kogame N, Asano T, von Birgelen C, Sabate M, Onuma Y, Serruys P
July 30, 2019 | 10.4244/EIJ-D-19-00566
Reply to the letter to the editor regarding the article “Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population”
Kok M, Sattar N, von Birgelen C
February 7, 2019 | 10.4244/EIJ-D-18-00235R
Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial
Kok M, Zocca P, Buiten R, Danse PW, Schotborgh C, Scholte M, Hartmann M, Stoel M, van Houwelingen K, Linssen GCM, Doggen CJM, von Birgelen C
October 19, 2018 | 10.4244/EIJ-D-18-00336
Stents and scaffolds
Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population
Kok M, von Birgelen C, Sattar N, Zocca P, Löwik M, Danse PW, Schotborgh C, Scholte M, Hartmann M, Kant GD, Doelman CJA, Gin M, Stoel M, van Houwelingen K, Linssen GCM, IJzerman M, Doggen CJM, van der Heijden LC
October 12, 2018 | 10.4244/EIJ-D-17-01067
Is the proximal left anterior descending coronary artery segment justifiably considered as the last frontier for stenting?
Roguin A, Solomonica A, von Birgelen C
September 20, 2018 | 10.4244/EIJV14I7A127
Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy
Asano T, Katagiri Y, Collet C, Tenekecioglu E, Miyazaki Y, Sotomi Y, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernandez-Antolin R, van de Harst P, Iñiguez A, Janssens L, Smits P, Wykrzykowska J, Ribeiro V, Pereira H, da Silva P, Piek J, Reiber J, von Birgelen C, Sabate M, Onuma Y, Serruys P
August 3, 2018 | 10.4244/EIJ-D-17-00461
First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trial
von Birgelen C, Asano T, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernández-Antolín R, van de Harst P, Iñiguez A, Janssens L, Smits P, Wykrzykowska J, Ribeiro V, Pereira H, da Silva P, Piek J, Onuma Y, Serruys P, Sabate M
April 20, 2018 | 10.4244/EIJ-D-17-00462
Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT
Zocca P, van der Heijden LC, Kok M, Löwik M, Hartmann M, Stoel M, Louwerenburg H, de Man F, Linssen GCM, Knottnerus I, Doggen CJM, van Houwelingen K, von Birgelen C
November 20, 2017 | 10.4244/EIJ-D-17-00634
Clinical outcomes after percutaneous coronary intervention with the COMBO stent versus Resolute Integrity and PROMUS Element stents: a propensity-matched analysis
Kalkman D, Kok M, van der Heijden LC, Woudstra P, Beijk M, Thijssen J, von Birgelen C, de Winter R
November 20, 2017 | 10.4244/EIJ-D-17-00301
A novel four-dimensional angiographic approach to assess dynamic superficial wall stress of coronary arteries in vivo: initial experience in evaluating vessel sites with subsequent plaque rupture
Wu X, von Birgelen C, Muramatsu T, Li Y, Holm N.R., Reiber J, Tu S
October 11, 2017 | 10.4244/EIJ-D-16-01020
Coronary interventions
Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III
Haude M, Ince H, Kische S, Abizaid A, Toelg R, Lemos P, Van Mieghem N, Verheye S, von Birgelen C, Christiansen E, Wijns W, Garcia-Garcia H, Waksman R
July 20, 2017 | 10.4244/EIJ-D-17-00254
Coronary interventions
First-in-man six-month results of a surface-modified coronary stent system in native coronary stenosis
Suwannasom P, Sotomi Y, Corti R, Kurz D, Roffi M, von Birgelen C, Buzzi S, Zucker A, Dijkstra J, Wykrzykowska J, de Winter R, Windecker S, Onuma Y, Serruys P, Daemen J, Räber L
April 20, 2017 | 10.4244/EIJ-D-16-00975
Coronary interventions
Three-year safety and efficacy of treating all-comers with newer-generation Resolute Integrity or PROMUS Element stents in the randomised DUTCH PEERS (TWENTE II) trial
van der Heijden LC, Kok M, Löwik M, Danse PW, Jessurun G, Hautvast R, van Houwelingen K, Stoel M, Hartmann M, Linssen GCM, Doggen CJM, von Birgelen C
April 20, 2017 | 10.4244/EIJ-D-16-00571
Coronary interventions
Evaluation of vascular healing of polymer-free sirolimus-eluting stents in native coronary artery stenosis: a serial follow-up at three and six months with optical coherence tomography imaging
Suwannasom P, Onuma Y, Benit E, Gach O, von Birgelen C, Hofma S, Sotomi Y, Bo X, Zhang Y-J, Gao R, Garcia-Garcia H, Wykrzykowska J, de Winter R, Serruys P
August 5, 2016 | 10.4244/EIJV12I5A97

Latest news

NEW ISSUE
Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…
Tetralogy of Fallot with acquired double right ventricular outflow tract
September 18, 2020
NEW
Device entrapment in chronic total occlusions
September 30, 2020
Editorial
Complex PCI: time for a universal definition
Joanna J. Wykrzykowska
September 30, 2020
JAA
This Week's JAA's: Impact of neoatherosclerosis in ISR on clinical outcome...
September 29, 2020
Spyral, Popular-Tavi, Sort out IX, Solve TAVI, and more
(Released thanks to the support of Biotronik)
September 30, 2020
Editorial
Integrating physiology in OCT
Gianluca Campo
September 23, 2020
Guidance Papers
Guidelines, consensus & position papers
August 28, 2020
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke